Clinical Trials Directory

Trials / Completed

CompletedNCT02570243

High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion

High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion Forearm Artery Occlusion

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,800 (actual)
Sponsor
University of Patras · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, multi-center, superiority study of parallel design. Patients are enrolled if they are older than 18 years old, are scheduled for 5 or 6 Fr diagnostic coronary angiography and the interventional cardiologist is willing to proceed with radial access. Patients are randomized before diagnostic catheterization to receive intravenously either 100IU/Kg or 50 IU/Kg of unfractionated heparin (UFH) in a 1:1 ratio. Patients are discharged usually within 4 to 6 hours after coronary angiography. Radial artery in each patient is evaluated either in-hospital or during a subsequent visit by one physician who is blinded to the actual antithrombotic treatment given. Radial artery is considered occluded if it exhibits ultrasonographically no antegrade flow signal both at baseline and after reevaluation on a second occasion, within 30 days after the index procedure. Initially patent arteries will not be reexamined and are thought to remain permanently patent. The investigators also monitor major bleeding (defined as ≥ 5g/dL decrease in hemoglobin or ≥15% decrease in hematocrit or any life-threatening bleeding (confirmed by MRI or computed tomography) and large local hematomas of the forearm (defined as those extending beyond the forearm).

Conditions

Interventions

TypeNameDescription
DRUGHigh dose of Unfractionated HeparinUnfractionated Heparin 100IU/Kg
DRUGStandard dose of Unfractionated heparinUnfractionated heparin 50IU/Kg

Timeline

Start date
2015-02-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2015-10-07
Last updated
2017-09-19

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT02570243. Inclusion in this directory is not an endorsement.